Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Patient-centered communication, patient satisfaction, and retention in care in assisted reproductive technology visits.

Borghi L, Leone D, Poli S, Becattini C, Chelo E, Costa M, De Lauretis L, Ferraretti AP, Filippini C, Giuffrida G, Livi C, Luehwink A, Palermo R, Revelli A, Tomasi G, Tomei F, Vegni E.

J Assist Reprod Genet. 2019 Jun;36(6):1135-1142. doi: 10.1007/s10815-019-01466-1. Epub 2019 May 10.

PMID:
31077010
2.

Removal of volatile gasoline compounds by indoor potted plants studied by pixel-based fingerprinting analysis.

Dela Cruz M, Tomasi G, Müller R, Christensen JH.

Chemosphere. 2019 Apr;221:226-234. doi: 10.1016/j.chemosphere.2018.12.125. Epub 2018 Dec 22.

PMID:
30640005
3.

Forensic Investigations of Diesel Oil Spills in the Environment Using Comprehensive Two-Dimensional Gas Chromatography-High Resolution Mass Spectrometry and Chemometrics: New Perspectives in the Absence of Recalcitrant Biomarkers.

Alexandrino GL, Tomasi G, Kienhuis PGM, Augusto F, Christensen JH.

Environ Sci Technol. 2019 Jan 2;53(1):550-559. doi: 10.1021/acs.est.8b05238. Epub 2018 Dec 18.

PMID:
30516975
4.

[A misleading prolonged asystole: a case of implantable loop recorder dehiscence].

Peruzza F, Maines M, Catanzariti D, Tomasi G, Angheben C, Del Greco M.

G Ital Cardiol (Rome). 2018 Apr;19(4):246-247. doi: 10.1714/2898.29220. Italian. No abstract available.

PMID:
29912240
5.

Substitution of venous for arterial blood sampling in the determination of regional rates of cerebral protein synthesis with L-[1-11C]leucine PET: A validation study.

Tomasi G, Veronese M, Bertoldo A, Smith CB, Schmidt KC.

J Cereb Blood Flow Metab. 2019 Sep;39(9):1849-1863. doi: 10.1177/0271678X18771242. Epub 2018 Apr 17.

PMID:
29664322
6.

Effects of shortened scanning intervals on calculated regional rates of cerebral protein synthesis determined with the L-[1-11C]leucine PET method.

Tomasi G, Veronese M, Bertoldo A, Beebe Smith C, Schmidt KC.

PLoS One. 2018 Apr 16;13(4):e0195580. doi: 10.1371/journal.pone.0195580. eCollection 2018.

7.

Doctor-couple communication during assisted reproductive technology visits.

Leone D, Borghi L, Del Negro S, Becattini C, Chelo E, Costa M, De Lauretis L, Ferraretti AP, Giuffrida G, Livi C, Luehwink A, Palermo R, Revelli A, Tomasi G, Tomei F, Filippini C, Vegni E.

Hum Reprod. 2018 May 1;33(5):877-886. doi: 10.1093/humrep/dey069.

PMID:
29635461
8.

Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.

Gonçalves LI, Dos Passos GR, Conzatti LP, Burger JLP, Tomasi GH, Zandoná MÉ, Azambuja LS, Gomes I, Franco A, Sato DK, Becker J.

Mult Scler Relat Disord. 2018 Feb;20:154-158. doi: 10.1016/j.msard.2018.01.015. Epub 2018 Jan 31.

PMID:
29414290
9.

Impact of tissue kinetic heterogeneity on PET quantification: case study with the L-[1-11C]leucine PET method for cerebral protein synthesis rates.

Veronese M, Bertoldo A, Tomasi G, Smith CB, Schmidt KC.

Sci Rep. 2018 Jan 17;8(1):931. doi: 10.1038/s41598-017-18890-x.

10.

Clinical impact, safety, and accuracy of the remotely monitored implantable loop recorder Medtronic Reveal LINQTM.

Maines M, Zorzi A, Tomasi G, Angheben C, Catanzariti D, Piffer L, Del Greco M.

Europace. 2018 Jun 1;20(6):1050-1057. doi: 10.1093/europace/eux187.

PMID:
29016753
11.

Characterizing Time Irreversibility in Disordered Fermionic Systems by the Effect of Local Perturbations.

Vardhan S, De Tomasi G, Heyl M, Heller EJ, Pollmann F.

Phys Rev Lett. 2017 Jul 7;119(1):016802. doi: 10.1103/PhysRevLett.119.016802. Epub 2017 Jul 6.

PMID:
28731748
12.

Breaking bad news in assisted reproductive technology: a proposal for guidelines.

Leone D, Menichetti J, Barusi L, Chelo E, Costa M, De Lauretis L, Ferraretti AP, Livi C, Luehwink A, Tomasi G, Vegni E.

Reprod Health. 2017 Jul 20;14(1):87. doi: 10.1186/s12978-017-0350-1. No abstract available.

13.

Density Propagator for Many-Body Localization: Finite-Size Effects, Transient Subdiffusion, and Exponential Decay.

Bera S, De Tomasi G, Weiner F, Evers F.

Phys Rev Lett. 2017 May 12;118(19):196801. doi: 10.1103/PhysRevLett.118.196801. Epub 2017 May 8.

PMID:
28548510
14.

Quantum Mutual Information as a Probe for Many-Body Localization.

De Tomasi G, Bera S, Bardarson JH, Pollmann F.

Phys Rev Lett. 2017 Jan 6;118(1):016804. doi: 10.1103/PhysRevLett.118.016804. Epub 2017 Jan 5.

PMID:
28106445
15.

Evaluation of chromatographic conditions in reversed phase liquid chromatography-mass spectrometry systems for fingerprinting of polar and amphiphilic plant metabolites.

Nielsen NJ, Tomasi G, Christensen JH.

Anal Bioanal Chem. 2016 Aug;408(21):5855-5865. doi: 10.1007/s00216-016-9700-z. Epub 2016 Jun 25.

PMID:
27344456
16.

Source apportionment of polycyclic aromatic hydrocarbons (PAHs) in sediments from Khuzestan province, Iran.

Lübeck JS, Poulsen KG, Knudsen SB, Soleimani M, Furbo S, Tomasi G, Christensen JH.

Mar Pollut Bull. 2016 Sep 15;110(1):584-590. doi: 10.1016/j.marpolbul.2016.05.057. Epub 2016 Jun 9. No abstract available.

PMID:
27289289
17.

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.

Trousil S, Kaliszczak M, Schug Z, Nguyen QD, Tomasi G, Favicchio R, Brickute D, Fortt R, Twyman FJ, Carroll L, Kalusa A, Navaratnam N, Adejumo T, Carling D, Gottlieb E, Aboagye EO.

Oncotarget. 2016 Jun 14;7(24):37103-37120. doi: 10.18632/oncotarget.9466.

18.

A combined proteomics and metabolomics approach to assess the effects of gold nanoparticles in vitro.

Gioria S, Lobo Vicente J, Barboro P, La Spina R, Tomasi G, Urbán P, Kinsner-Ovaskainen A, François R, Chassaigne H.

Nanotoxicology. 2016 Aug;10(6):736-48. doi: 10.3109/17435390.2015.1121412. Epub 2016 Feb 10.

19.

Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PET.

Kenny LM, Tomasi G, Turkheimer F, Larkin J, Gore M, Brock CS, Mangar S, Aboagye EO.

EJNMMI Res. 2014 Dec;4(1):30. doi: 10.1186/s13550-014-0030-x. Epub 2014 Aug 8.

20.

An untargeted gas chromatography mass spectrometry metabolomics platform for marine polychaetes.

Fernández-Varela R, Tomasi G, Christensen JH.

J Chromatogr A. 2015 Mar 6;1384:133-41. doi: 10.1016/j.chroma.2015.01.025. Epub 2015 Jan 19.

PMID:
25660527
21.

Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.

Naganawa M, Zheng MQ, Nabulsi N, Tomasi G, Henry S, Lin SF, Ropchan J, Labaree D, Tauscher J, Neumeister A, Carson RE, Huang Y.

J Cereb Blood Flow Metab. 2014 Nov;34(11):1818-25. doi: 10.1038/jcbfm.2014.150. Epub 2014 Sep 3.

22.

Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.

Naganawa M, Jacobsen LK, Zheng MQ, Lin SF, Banerjee A, Byon W, Weinzimmer D, Tomasi G, Nabulsi N, Grimwood S, Badura LL, Carson RE, McCarthy TJ, Huang Y.

Neuroimage. 2014 Oct 1;99:69-79. doi: 10.1016/j.neuroimage.2014.05.033. Epub 2014 May 17.

23.

Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.

Bloomfield MA, Pepper F, Egerton A, Demjaha A, Tomasi G, Mouchlianitis E, Maximen L, Veronese M, Turkheimer F, Selvaraj S, Howes OD.

Neuropsychopharmacology. 2014 Sep;39(10):2397-404. doi: 10.1038/npp.2014.87. Epub 2014 Apr 10.

24.

Positron emission tomography imaging with 18F-labeled ZHER2:2891 affibody for detection of HER2 expression and pharmacodynamic response to HER2-modulating therapies.

Trousil S, Hoppmann S, Nguyen QD, Kaliszczak M, Tomasi G, Iveson P, Hiscock D, Aboagye EO.

Clin Cancer Res. 2014 Mar 15;20(6):1632-43. doi: 10.1158/1078-0432.CCR-13-2421. Epub 2014 Feb 3.

25.

Radiolabeled RGD tracer kinetics annotates differential αvβ 3 integrin expression linked to cell intrinsic and vessel expression.

Alam IS, Witney TH, Tomasi G, Carroll L, Twyman FJ, Nguyen QD, Aboagye EO.

Mol Imaging Biol. 2014 Aug;16(4):558-66. doi: 10.1007/s11307-013-0710-3. Epub 2013 Dec 6.

PMID:
24310722
26.

Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer.

Challapalli A, Barwick T, Tomasi G, O' Doherty M, Contractor K, Stewart S, Al-Nahhas A, Behan K, Coombes C, Aboagye EO, Mangar S.

Nucl Med Commun. 2014 Jan;35(1):20-9. doi: 10.1097/MNM.0000000000000014.

PMID:
24201549
27.

Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial.

Carbonell JL, Acosta R, Pérez Y, Garcés R, Sánchez C, Tomasi G.

ISRN Obstet Gynecol. 2013 Jul 29;2013:649030. doi: 10.1155/2013/649030. eCollection 2013.

28.

18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.

Challapalli A, Kenny LM, Hallett WA, Kozlowski K, Tomasi G, Gudi M, Al-Nahhas A, Coombes RC, Aboagye EO.

J Nucl Med. 2013 Sep;54(9):1551-6. doi: 10.2967/jnumed.112.118760. Epub 2013 Aug 15.

29.

Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.

Zhao L, Ashek A, Wang L, Fang W, Dabral S, Dubois O, Cupitt J, Pullamsetti SS, Cotroneo E, Jones H, Tomasi G, Nguyen QD, Aboagye EO, El-Bahrawy MA, Barnes G, Howard LS, Gibbs JS, Gsell W, He JG, Wilkins MR.

Circulation. 2013 Sep 10;128(11):1214-24. doi: 10.1161/CIRCULATIONAHA.113.004136. Epub 2013 Jul 30.

PMID:
23900048
30.

Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial.

Esteve JL, Acosta R, Pérez Y, Rodriguez B, Seigler I, Sanchez C, Tomasi G.

Int J Womens Health. 2013 Jun 25;5:361-9. doi: 10.2147/IJWH.S42770. Print 2013.

31.

Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial.

Carbonell JL, Acosta R, Pérez Y, Marrero AG, Trellez E, Sánchez C, Tomasi G.

Int J Womens Health. 2013 Mar 19;5:115-24. doi: 10.2147/IJWH.S33125. Print 2013.

32.

Introduction to the analysis of PET data in oncology.

Tomasi G, Aboagye EO.

J Pharmacokinet Pharmacodyn. 2013 Aug;40(4):419-36. doi: 10.1007/s10928-013-9307-3. Epub 2013 Feb 27. Review.

PMID:
23443280
33.

Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.

Tomasi G, Nabulsi N, Zheng MQ, Weinzimmer D, Ropchan J, Blumberg L, Brown-Proctor C, Ding YS, Carson RE, Huang Y.

J Nucl Med. 2013 Apr;54(4):600-8. doi: 10.2967/jnumed.112.112672. Epub 2013 Feb 19.

34.

Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.

Zheng MQ, Nabulsi N, Kim SJ, Tomasi G, Lin SF, Mitch C, Quimby S, Barth V, Rash K, Masters J, Navarro A, Seest E, Morris ED, Carson RE, Huang Y.

J Nucl Med. 2013 Mar;54(3):455-63. doi: 10.2967/jnumed.112.109512. Epub 2013 Jan 25.

35.

Comparative assessment of segmentation algorithms for tumor delineation on a test-retest [(11)C]choline dataset.

Tomasi G, Shepherd T, Turkheimer F, Visvikis D, Aboagye E.

Med Phys. 2012 Dec;39(12):7571-9. doi: 10.1118/1.4761952.

PMID:
23231305
36.

PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.

Tomasi G, Rosso L.

Curr Opin Pharmacol. 2012 Oct;12(5):569-75. doi: 10.1016/j.coph.2012.07.016. Epub 2012 Aug 15. Review.

PMID:
22901680
37.

The zygote.

Papale L, Fiorentino A, Montag M, Tomasi G.

Hum Reprod. 2012 Aug;27 Suppl 1:i22-49. doi: 10.1093/humrep/des205. Epub 2012 Jul 18. No abstract available.

PMID:
22811310
38.

Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies.

Yaqub M, van Berckel BN, Schuitemaker A, Hinz R, Turkheimer FE, Tomasi G, Lammertsma AA, Boellaard R.

J Cereb Blood Flow Metab. 2012 Aug;32(8):1600-8. doi: 10.1038/jcbfm.2012.59. Epub 2012 May 16.

39.

Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.

Contractor K, Challapalli A, Tomasi G, Rosso L, Wasan H, Stebbing J, Kenny L, Mangar S, Riddle P, Palmieri C, Al-Nahhas A, Sharma R, Turkheimer F, Coombes RC, Aboagye E.

Phys Med Biol. 2012 Jun 7;57(11):3419-33. doi: 10.1088/0031-9155/57/11/3419. Epub 2012 May 10.

PMID:
22572708
40.

Chemometric analysis of gas chromatography with flame ionisation detection chromatograms: a novel method for classification of petroleum products.

Nielsen NJ, Ballabio D, Tomasi G, Todeschini R, Christensen JH.

J Chromatogr A. 2012 May 18;1238:121-7. doi: 10.1016/j.chroma.2012.03.062. Epub 2012 Mar 27.

PMID:
22503620
41.

Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery.

Carbonell Esteve JL, Riverón AM, Cano M, Ortiz AI, Valle A, Texidó CS, Tomasi G.

Int J Womens Health. 2012;4:75-84. doi: 10.2147/IJWH.S28103. Epub 2012 Mar 13.

42.

Double-input compartmental modeling and spectral analysis for the quantification of positron emission tomography data in oncology.

Tomasi G, Kimberley S, Rosso L, Aboagye E, Turkheimer F.

Phys Med Biol. 2012 Apr 7;57(7):1889-906. doi: 10.1088/0031-9155/57/7/1889. Epub 2012 Mar 16.

PMID:
22421332
43.

Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.

Witney TH, Alam IS, Turton DR, Smith G, Carroll L, Brickute D, Twyman FJ, Nguyen QD, Tomasi G, Awais RO, Aboagye EO.

Clin Cancer Res. 2012 Feb 15;18(4):1063-72. doi: 10.1158/1078-0432.CCR-11-2462. Epub 2012 Jan 10.

44.

Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, Tomasi G, Al-Nahhas A, Mapelli P, Kenny LM, Tadrous P, Coombes RC, Aboagye EO, Mangar S.

Clin Cancer Res. 2011 Dec 15;17(24):7673-83. doi: 10.1158/1078-0432.CCR-11-2048. Epub 2011 Oct 28.

45.

icoshift: An effective tool for the alignment of chromatographic data.

Tomasi G, Savorani F, Engelsen SB.

J Chromatogr A. 2011 Oct 28;1218(43):7832-40. doi: 10.1016/j.chroma.2011.08.086. Epub 2011 Sep 3.

PMID:
21930276
46.

Quantification of receptor-ligand binding with [¹⁸F]fluciclatide in metastatic breast cancer patients.

Tomasi G, Kenny L, Mauri F, Turkheimer F, Aboagye EO.

Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2186-97. doi: 10.1007/s00259-011-1907-9. Epub 2011 Sep 3.

PMID:
21892622
47.

Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.

Tomasi G, Turkheimer F, Aboagye E.

Mol Imaging Biol. 2012 Apr;14(2):131-46. doi: 10.1007/s11307-011-0514-2. Review.

PMID:
21842339
48.

The use of environmental metabolomics to determine glyphosate level of exposure in rapeseed (Brassica napus L.) seedlings.

Petersen IL, Tomasi G, Sørensen H, Boll ES, Hansen HC, Christensen JH.

Environ Pollut. 2011 Oct;159(10):3071-7. doi: 10.1016/j.envpol.2011.04.005. Epub 2011 May 8.

PMID:
21555174
49.

Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195.

Tomasi G, Bertoldo A, Cobelli C, Pavese N, Tai YF, Hammers A, Turkheimer FE.

Neuroimage. 2011 Apr 1;55(3):942-53. doi: 10.1016/j.neuroimage.2010.12.056. Epub 2010 Dec 30.

PMID:
21195193
50.

A novel approach for characterization of polycyclic aromatic hydrocarbon (PAH) pollution patterns in sediments from Guanabara Bay, Rio de Janeiro, Brazil.

Christensen JH, Tomasi G, de Lemos Scofield A, de Fatima Guadalupe Meniconi M.

Environ Pollut. 2010 Oct;158(10):3290-7. doi: 10.1016/j.envpol.2010.07.015. Epub 2010 Aug 14.

PMID:
20709434

Supplemental Content

Loading ...
Support Center